Correlation Between Starbucks and Microbot Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Starbucks and Microbot Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Starbucks and Microbot Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Starbucks and Microbot Medical, you can compare the effects of market volatilities on Starbucks and Microbot Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Starbucks with a short position of Microbot Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Starbucks and Microbot Medical.

Diversification Opportunities for Starbucks and Microbot Medical

0.43
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Starbucks and Microbot is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Starbucks and Microbot Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Microbot Medical and Starbucks is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Starbucks are associated (or correlated) with Microbot Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Microbot Medical has no effect on the direction of Starbucks i.e., Starbucks and Microbot Medical go up and down completely randomly.

Pair Corralation between Starbucks and Microbot Medical

Given the investment horizon of 90 days Starbucks is expected to generate 0.49 times more return on investment than Microbot Medical. However, Starbucks is 2.02 times less risky than Microbot Medical. It trades about 0.19 of its potential returns per unit of risk. Microbot Medical is currently generating about 0.06 per unit of risk. If you would invest  9,672  in Starbucks on August 31, 2024 and sell it today you would earn a total of  574.00  from holding Starbucks or generate 5.93% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Starbucks  vs.  Microbot Medical

 Performance 
       Timeline  
Starbucks 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Starbucks are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly sluggish basic indicators, Starbucks may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Microbot Medical 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Microbot Medical are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Microbot Medical unveiled solid returns over the last few months and may actually be approaching a breakup point.

Starbucks and Microbot Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Starbucks and Microbot Medical

The main advantage of trading using opposite Starbucks and Microbot Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Starbucks position performs unexpectedly, Microbot Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Microbot Medical will offset losses from the drop in Microbot Medical's long position.
The idea behind Starbucks and Microbot Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk